tenofovir disoproxil &#160; ingelesa (Q27132753)

Tenofovir disoproxil (ingelesa)

18 azaroa 2016

formula kimikoa

C₁₉H₃₀N₅O₁₀P

Erreferentzia bat

Tenofovir disoproxil (ingelesa)

18 azaroa 2016

SMILES

CC(C)OC(=O)OCOP(=O)(COC(C)CN1C=NC2=C1N=CN=C2N)OCOC(=O)OC(C)C

Erreferentzia bat

Tenofovir disoproxil (ingelesa)

18 azaroa 2016

isomeric SMILES ^ingelesa

C[C@H](CN1C=NC2=C1N=CN=C2N)OCP(=O)(OCOC(=O)OC(C)C)OCOC(=O)OC(C)C

Erreferentzia bat

Tenofovir disoproxil (ingelesa)

18 azaroa 2016

active ingredient in ^ingelesa

Tenofovir Disoproxil Mylan ^ingelesa

Erreferentzia bat

European Medicines Agency product number ^ingelesa

EMEA/H/C/004049

http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/human/medicines/004049/human_med_002048.jsp

22 martxoa 2017

Viread ^ingelesa

Erreferentzia bat

RxNorm ^ingelesa

RxNorm ID ^ingelesa

323726

14 otsaila 2018

medical condition treated ^ingelesa

B hepatitis

Erreferentzia bat

Drug Indications Extracted from FAERS ^ingelesa

2 urria 2018

chronic hepatitis B ^ingelesa

Erreferentzia bat

Drug Indications Extracted from FAERS ^ingelesa

Hartutako Immuno Eskasiaren Sindromea

2 urria 2018

Erreferentzia bat

Drug Indications Extracted from FAERS ^ingelesa

Droga eta Elikagaien Administrazioa

2 urria 2018

human immunodeficiency virus infectious disease ^ingelesa

hasiera data

17 urtarrila 2012

nork onartua

Erreferentzia bat

Inxight: Drugs Database ^ingelesa

2 azaroa 2018

https://drugs.ncats.io/drug/F4YU4LON7I

https://aidsinfo.nih.gov/drugs/290/tenofovir-disoproxil-fumarate/0/patient

B hepatitis

hasiera data

17 urtarrila 2012

nork onartua

Droga eta Elikagaien Administrazioa

Erreferentzia bat

Inxight: Drugs Database ^ingelesa

2 azaroa 2018

https://drugs.ncats.io/drug/F4YU4LON7I

https://aidsinfo.nih.gov/drugs/290/tenofovir-disoproxil-fumarate/0/patient

significant drug interaction ^ingelesa

nabumetone ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Naproxeno

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

celecoxib ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

diklofenako

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Piroxicam

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

meloxicam ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

(RS)-fenoprofen ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

(+-)-flurbiprofen ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Ibuprofeno

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

indomethacin ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

(RS)-ketoprofen ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

(RS)-etodolac ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

sulindac ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

parecoxib ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

aceclofenac ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

tenoxicam ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

giltzurruneko gutxiegitasun

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

atazanavir ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

nabumetone ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Naproxeno

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

celecoxib ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

diklofenako

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Piroxicam

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

meloxicam ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

(RS)-fenoprofen ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

(+-)-flurbiprofen ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Ibuprofeno

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

indomethacin ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

(RS)-ketoprofen ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

(RS)-etodolac ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

sulindac ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

parecoxib ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

aceclofenac ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

tenoxicam ^ingelesa

side effect ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

didanosine ^ingelesa

side effect ^ingelesa

lactic acidosis ^ingelesa

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

didanosine ^ingelesa

side effect ^ingelesa

neuropatia periferiko

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

didanosine ^ingelesa

side effect ^ingelesa

beherako

Erreferentzia bat

established ^ingelesa

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

didanosine ^ingelesa

side effect ^ingelesa

pankreatitis

Erreferentzia bat

established ^ingelesa

InChI=1S/C19H30N5O10P/c1-12(2)33-18(25)28-9-31-35(27,32-10-29-19(26)34-13(3)4)11-30-14(5)6-24-8-23-15-16(20)21-7-22-17(15)24/h7-8,12-14H,6,9-11H2,1-5H3,(H2,20,21,22)/t14-/m1/s1

A reference set of clinically relevant adverse drug-drug interactions ^ingelesa

Commons-eko kategoria

Tenofovir disoproxil

0 erreferentzia

katalogo

CAS COVID-19 Anti-Viral Candidate Compounds ^ingelesa

0 erreferentzia

Identifikatzaileak

InChI

Erreferentzia bat

Tenofovir disoproxil (ingelesa)

18 azaroa 2016

2 erreferentzia

Tenofovir disoproxil (ingelesa)

18 azaroa 2016

ChEBI release 2020-09-01 ^ingelesa

CAS zenbakia

201341-05-1

2 erreferentzia

Global Substance Registration System ^ingelesa

UNII

F4YU4LON7I

tenofovir disoproxil (ingelesa)

18 azaroa 2016

CAS Common Chemistry ^ingelesa

9 apirila 2021

https://commonchemistry.cas.org/detail?cas_rn=201341-05-1

ChemSpider-ren identifikatzailea

4587262

Erreferentzia bat

ChemSpider-ren identifikatzailea

ChemSpider ^ingelesa

4587262

Tenofovir disoproxil (ingelesa)

18 azaroa 2016

2 erreferentzia

Tenofovir disoproxil (ingelesa)

18 azaroa 2016

InChIKey ^ingelesa

Reaxys registry number ^ingelesa

9018187

Erreferentzia bat

ChEBI-ren identifikatzailea

ChEBI ^ingelesa

63717

tenofovir disoproxil (ingelesa)

ChEBI-ren identifikatzailea

7 urria 2016

63717

mapping relation type ^ingelesa

exact match ^ingelesa

2 erreferentzia

ChEMBL-en identifikatzailea

ChEMBL ^ingelesa

CHEMBL1538

TENOFOVIR DISOPROXIL (ingelesa)

18 azaroa 2016

InChI=1S/C19H30N5O10P/c1-12(2)33-18(25)28-9-31-35(27,32-10-29-19(26)34-13(3)4)11-30-14(5)6-24-8-23-15-16(20)21-7-22-17(15)24/h7-8,12-14H,6,9-11H2,1-5H3,(H2,20,21,22)/t14-/m1/s1

International Chemical Identifier ^ingelesa

InChI

ChEMBL-en identifikatzailea

CHEMBL1538

Erreferentzia bat

ChEMBL-en identifikatzailea

ChEMBL ^ingelesa

CHEMBL1538

TENOFOVIR DISOPROXIL (ingelesa)

18 azaroa 2016

SureChEMBL ID ^ingelesa

SCHEMBL52793

2 erreferentzia

based on heuristic ^ingelesa

inferred from InChIKey ^ingelesa

InChIKey ^ingelesa

UniChem compound ID ^ingelesa

520

Erreferentzia bat

UniChem ^ingelesa

DSSTox substance ID ^ingelesa

DTXSID5052757

2 erreferentzia

Mapping file of InChIStrings, InChIKeys and DTXSIDs for the EPA CompTox Dashboard ^ingelesa

InChIKey ^ingelesa

DSSTOX compound identifier ^ingelesa

DTXCID2031249

0 erreferentzia

EC zenbakia

606-442-6

Erreferentzia bat

ECHA Substance Infocard database ^ingelesa

ECHA Substance Infocard ID ^ingelesa

100.114.051

27 abendua 2018

2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, 1,9-bis(1-methylethyl) ester, 5-oxide (ingelesa)

quotation ^ingelesa

CAS no.: 201341-05-1 (ingelesa)

ECHA Substance Infocard ID ^ingelesa

100.114.051

Erreferentzia bat

ECHA Substance Infocard database ^ingelesa

ECHA Substance Infocard ID ^ingelesa

100.114.051

27 abendua 2018

2,4,6,8-Tetraoxa-5-phosphanonanedioic acid, 5-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-, 1,9-bis(1-methylethyl) ester, 5-oxide (ingelesa)

quotation ^ingelesa

CAS no.: 201341-05-1 (ingelesa)

RxNorm ID ^ingelesa

300195

Erreferentzia bat

Global Substance Registration System ^ingelesa

UNII

F4YU4LON7I